68
Views
0
CrossRef citations to date
0
Altmetric
Review Article

Comparative toxicity and distribution of InCl3 and In2O3 nanoparticles in rats

Pages 116-120 | Received 04 Dec 2015, Accepted 11 Apr 2016, Published online: 07 Jul 2016
 

Abstract

Recent studies have reported that metal oxide nanoparticles had potential adverse effects. In this research, the tissue distribution and toxic effects of administered InCl3 (bulk) and indium (III) oxide Nanoparticles (In2O3-NPs < 45 nm, BET of 43.6 m2/g and average hydrodynamic diameter of 79.97 nm) were investigated. Male Wistar rats were treated with a single intraperitoneal injection of InCl3 (bulk) and In2O3-NPs (2 mg/kg body weight, daily) for four consecutive weeks. Indium, copper and iron concentrations were measured by using ICP-OES. The indium levels were highest in the liver, followed in decreasing order by the levels in the spleen, kidney and intestine. The concentration of indium in In2O3-NPs exposed rats was more than InCl3 group and indium exposure caused significant decrease on Hb, RBC levels, PLT count and copper and iron concentrations in organs, which is probably due to an interference that could take place by indium (III) through iron (III) uptake mechanism.

Acknowledgements

Authors are thankful to Prof. Alireza Badiei, for providing working facilities.

Declaration of interest

The author(s) declare that they have no competing interests.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.